We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH
RNS Number : 6478E
Dechra Pharmaceuticals PLC
19 October 2018
Date: 19 October 2018
Dechra(R) Pharmaceuticals PLC
Results of Annual General Meeting (AGM)
AGM Meeting Date: 10.30 am on 19 October 2018
Issued Share Capital at meeting date: 102,336,635
Number of shareholders in attendance: 9
All resolutions were passed on a show of hands.
Details of the proxy voting instructions lodged prior to the AGM are set out below:
Resolution (No. as noted Total For (1) Total Against Withheld on proxy form) (2) No. of % of No. of % of No. of votes votes vote votes vote ----------- ------- ---------- ------ ------------- Resolution 1: To receive the accounts, the Strategic Report, the Directors' Report and the Auditor's Report 73,623,740 95.88 3,162,913 4.12 377,261 ----------- ------- ---------- ------ ------------- Resolution 2: To approve the Directors' Remuneration Report 76,045,670 98.58 1,092,914 1.42 25,330 ----------- ------- ---------- ------ ------------- Resolution 3: To declare a final dividend 77,160,743 100.00 3,172 0.00 0 ----------- ------- ---------- ------ ------------- Resolution 4: To re-elect William Anthony Rice 71,931,907 93.24 5,212,000 6.76 20,007 ----------- ------- ---------- ------ ------------- Resolution 5: To re-elect Ian Page 76,265,790 98.84 898,039 1.16 86 ----------- ------- ---------- ------ ------------- Resolution 6: To re-elect Richard Cotton 76,089,363 98.61 1,074,466 1.39 86 ----------- ------- ---------- ------ ------------- Resolution 7: To re-elect Anthony Griffin 76,248,926 98.81 914,902 1.19 86 ----------- ------- ---------- ------ ------------- Resolution 8: To re-elect Julian Heslop 76,471,131 99.10 692,698 0.90 86 ----------- ------- ---------- ------ ------------- Resolution 9: To re-elect Ishbel Macpherson 76,540,810 99.22 603,098 0.78 20,007 ----------- ------- ---------- ------ ------------- Resolution 10: To re-elect Lawson Macartney 76,643,113 99.33 520,716 0.67 86 ----------- ------- ---------- ------ ------------- Resolution 11: To re-appoint PricewaterhouseCoopers as external auditor of the Company 76,021,787 98.52 1,141,654 1.48 473 ----------- ------- ---------- ------ ------------- Resolution 12: To authorise the Audit Committee to determine the remuneration of the external auditor 76,655,223 99.34 508,169 0.66 523 ----------- ------- ---------- ------ ------------- Resolution 13: To authorise the Directors to allot shares to specific limits 75,498,018 97.84 1,664,325 2.16 1,572 ----------- ------- ---------- ------ ------------- Resolution 14: To disapply the pre-emption rights 73,792,966 95.63 3,369,827 4.37 1,122 ----------- ------- ---------- ------ ------------- Resolution 15: To disapply additional pre-emption rights 73,637,601 95.43 3,523,885 4.57 2,428 ----------- ------- ---------- ------ ------------- Resolution 16: To authorise the Company to purchase its own shares 76,382,960 99.00 773,210 1.00 7,744 ----------- ------- ---------- ------ ------------- Resolution 17: To call general meetings (other than an AGM) on not less than 14 clear days' notice 75,446,021 97.77 1,717,894 2.23 0 ----------- ------- ---------- ------ ------------- Resolution 18: (a) To approve the rules of the Dechra Global Save As You Earn Scheme 2018 (2018 SAYE Plan); and (b) To authorise the Directors to adopt further plans based on the 2018 SAYE Plan 76,738,556 99.45 423,701 0.55 1,658 ----------- ------- ---------- ------ -------------
Notes
1. Includes discretionary votes.
2. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.
3. Resolutions 1 to 13 and Resolution 18 were ordinary resolutions, requiring more than 50% of shareholder votes to be "For" the resolutions.
4. Resolutions 14 to 17 were special resolutions, requiring more than 75% of shareholder votes to be "For" the resolutions.
5. Votes tendered in respect of 77,163,915 shares representing 75.40% of the issued share capital.
In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. The majority of Dechra's products are focused on key therapeutic categories where we have leading market positions, and many of our products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information, please visit: www.dechra.com.
Trademarks
Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGEAAENFDSPFFF
(END) Dow Jones Newswires
October 19, 2018 08:37 ET (12:37 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions